PEXIVAS
2020
Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis
In 704 patients with severe ANCA-associated vasculitis, plasma exchange did not reduce death or end-stage kidney disease compared with no plasma exchange.
Result
Efficacy: Composite of death or end-stage kidney diseaseHR 0.86 (95% CI 0.65-1.13)
Below 1 favours plasma exchange, above 1 favours no plasma exchange.
Also reported: Reduced-dose steroids non-inferior with fewer serious infections.
- Subtopic
- ANCA vasculitis
- Design
- 2×2 factorial RCT
- Relevance
- Practice-defining: a trial the guidelines cite as evidence.
- Source
- Walsh M, et al. N Engl J Med. 2020;382(7):622-631.doi 10.1056/NEJMoa1803537
Discussion & critique
Ended routine plasma exchange in ANCA vasculitis and made reduced-dose steroid schedules standard.